Biotech Breakouts | September 28th FDA Insider Watch List

Contents

1 What do you get for your money with Kyle Dennis’ Program?

What do you get for your money with Kyle Dennis’ Program?

>> Ready To Try Kyle Dennis’ Program? Click Here To Find Your Bonuses <<

Products	Price	Quantity	Total
Biotech Nucleus Included FREE with Black Optics	$3,997.00 $0.00	1	$0.00
Option Rocket Included FREE with Black Optics	$1,997.00 $0.00	1	$0.00
FDA Insider and Sniper Report Included FREE with Black Optics	$997.00 $0.00	1	$0.00
Black Optics Black Optics encompasses every product/service offering I have above to give you the step-by-step system to help you find clarity amongst the chaos and accelerate your stock trading performance at an unmatched rate of speed.	$2,997.00	1	$2,997.00

Well, things are heating up really quickly lately!

Just 1 day and I was able to ring the register on ADAP over $13! Gains are coming quickly – which I always love!

Option Rocket members also enjoyed a nice 50% win at the open on CYBR. Congrats to those in there!

I also added to some gains in the Biotech Nucleus Room by trading huge winnerACHV today.

All around, money is rolling in!

This book has helped thousands of other traders learn the basics of biotech, and how to easily spot winning trades.

Whether you are new trader or a 30-year veteran, this book will help you find stocks that are primed to make parabolic moves. These strategies are Kyle’s secret weapons that have help him net over $3 Million in profits…and they are all yours for free.

This is normally $97.00, but it’s yours FREE!

I still hold ACHN and it is performing well. I also picked up short term (1-3 day swing trades) in ACRX and CVM. I like to “strike when the iron is hot” and be more active when the markets are easy.

So, that is why I’m including some of these shorter term trades right now.

I hope you are enjoying them and making money!

I’ll be refining the watch list this weekend and adjusting our “zones”, so stay tuned for that as well!

Reminder: Charts are updated every Sunday evening for the next week!

New Catalyst Swing Names (1-4 week holds) that I am watching

Adaptimmune Therapeutics (ADAP)

Catalyst Dates: Late breaking Phase 1 data due out October 19-23

Buy Zone: $11.50 to $12.00

Profit Zone: $13.00 or higher

Stop Zone: $11.25 or below

Karyopharm Therapeutics (KPTI)

Catalyst Dates: Late breaking data due out October 19-23

Buy Zone: $16.50 to $17.50

Profit Zone: $18.00 or higher

Stop Zone: $16.05 or below

Catalyst Swing Names (1-4 week holds) that I am watching

Axsome Therapeutics (AXSM)

Catalyst Dates: Phase 2 data for major depressive disorder due in the fourth quarter. Phase 3 data due out in the second half of 2018. Another Phase 2 interim data due out in the 4th quarter. R&D day October 18th.

Buy Zone: $3.10 to $3.40

Profit Zone: $4.00 or higher

Stop Zone: $2.95 or below

Immunogen (IMGN)

Catalyst Dates: Phase 1b/2 data due out October 19-23

Buy Zone: $9.00 to $9.35

Profit Zone: $10.30 or higher

Stop Zone: $8.70 or below

Clovis Oncology (CLVS)

Catalyst Dates: Phase 2 data due October 21

Buy Zone: $31.50 to $32.50

Profit Zone: $35.00 or higher

Stop Zone: $30.00 or below

Catalyst Biosciences (CBIO)

Catalyst Dates: Updated data due out late 3Q or early 4Q

Buy Zone: $10.00 to $10.30

Profit Zone: $11.50 or higher

Stop Zone: $9.50 or below

Catalyst Pharmaceuticals (CPRX)

Catalyst Dates: FDA approval date of November 28th

Buy Zone: $2.90 to $3.20

Profit Zone: $3.80 or higher

Stop Zone: $2.70 or below

Sellas Life Corp (SLS)

Catalyst Dates: Phase 2 interim data due out October 19-23

Buy Zone: $1.05 to $1.15

Profit Zone: $1.50 or higher

Stop Zone: $.95 or below

Epizyme (EPZM)

Catalyst Dates: Phase 2 data update October 19-23.

Buy Zone: $10.00 to $10.30

Profit Zone: $11.50 or higher

Stop Zone: $9.50 or below

Halozyme (HALO)

Catalyst Dates: Present updated pancreatic cancer data October 19-23

Buy Zone: $17.25 to $17.75

Profit Zone: $18.50 or higher

Stop Zone: $16.80 or below

EyePoint Pharmaceuticals (EYPT)

Catalyst Dates: FDA approval date of November 5th

Buy Zone: $2.40 to $2.60

Profit Zone: $3.00 or higher

Stop Zone: $2.10 or below

AVEO Pharmaceuticals (AVEO)

Catalyst Dates: Updated Phase 2 data due out October 19-23 and Phase 3 data due out in the Fourth Quarter. Also, could get a press release on news of their completed Phase 3 trial.

Buy Zone: $2.55 to $2.75

Profit Zone: $2.95 or higher

Stop Zone: $2.50 or below